IMTX
Immatics Nv
NASDAQ · Biotechnology
$9.63
+1.06 (+12.37%)
Open$8.86
Previous Close$8.57
Day High$9.75
Day Low$8.71
52W High$12.41
52W Low$3.30
Volume—
Avg Volume360.1K
Market Cap1.29B
P/E Ratio—
EPS$-0.96
SectorBiotechnology
Analyst Ratings
Strong Buy
17 analysts
Price Target
+702.2% upside
Current
$9.63
$9.63
Target
$77.25
$77.25
$52.47
$77.25 avg
$103.74
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 195.63M | 118.68M | 326.37M |
| Net Income | 19.10M | 10.43M | -48,914,216 |
| Profit Margin | 9.8% | 9.3% | -15.0% |
| EBITDA | -37,417,215 | -21,565,463 | -62,378,752 |
| Free Cash Flow | — | — | -30,588,227 |
| Rev Growth | +64.8% | +64.8% | -5.3% |
| Debt/Equity | 0.03 | 0.03 | 0.61 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |